
Data presented at the 62nd Annual ASH Meeting demonstrated the clinical utility of Adaptive Biotechnologies’ clonoSEQ next-generation sequencing to detect MRD in multiple myeloma patients.

Data presented at the 62nd Annual ASH Meeting demonstrated the clinical utility of Adaptive Biotechnologies’ clonoSEQ next-generation sequencing to detect MRD in multiple myeloma patients.

During a session at the at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts outlined the benefits and limitations of pharmacological, surgical, and lifestyle interventions for pediatric patients with obesity.

Between the first introduction of population carrier screening in 2008 and its expansion to the full Israeli population in 2013, the mean rate of prenatal diagnoses per year was 4.66, and this rose to 7.75 between 2014 and 2017, a 66% increase.

With leading health experts warning of a grim few months ahead as the pandemic continues to rage, and as a vaccine launch grows more imminent, this 3-part series explores the impact of existing health disparities on COVID-19 and some potential solutions.

Coronavirus disease 2019 (COVID-19) vaccine doses to be administered this week in UK; President-elect Joe Biden nominates HHS secretary, CDC director; Biotechnology Innovation Organization sues to block new international drug pricing policy.

Twelve-month maintenance data from this study demonstrate the survival and response benefits associated with daratumumab, noted Mark Wildgust, PhD, vice president of Global Medical Affairs/Oncology at Janssen.

Zanubrutinib has a cleaner kinome than ibrutinib in that it hits fewer off-target kinases, said Ian Flinn, MD, PhD, director of lymphoma research at Sarah Cannon Research Institute.

At the National Alliance’s 2020 Annual Forum, a chief focus was spotlighting issues within the workplace exacerbated by the coronavirus disease 2019 pandemic such as mental health and disparities in availability of health care services.

Overall survival from early breast cancer has steadily been increasing; however, simultaneous increases in obesity and obesity-related comorbidities may have contributed to the survival disparity seen between these patient groups.

Researchers from the University of California San Francisco published their results in the Journal of Urology.

There have been exceptional results seen in CARTITUDE-1, stated Deepu Madduri, MD, assistant professor at the Icahn School of Medicine at Mount Sinai in New York City and associate director of its cellular therapy program.

Research presented at this year’s annual meeting of the Radiological Society of North America shows the possible impact of food or housing insecurity on follow-up appointments for breast cancer.

It’s important to get the medicine and the science right, but we must not lose sight of that human connection between patient and caregiver, emphasized Robert K. Massie, Jr, PhD, MA, of the Society for Progress. Massie will speak during the virtual ASH meeting.

In the real world, the persistence rate with secukinumab to treat psoriatic arthritis was higher than with ustekinumab.

A combination of stay-at-home orders and vape and smoke shop closures contributed to why many young adults and people under 21 years old quit or reduced vaping.

Researchers discuss the latest advances in technology-enabled care under development for Parkinson disease, as well as potential challenges to achieve full integration.

For infants, the main driver of these increased costs came from inpatient visits vs outpatient visits among children and juveniles.

A recent prospective, observational study investigated the use of direct oral anticoagulants for use in patients with postoperative atrial fibrillation and found favorable safety and efficacy results.

Two studies presented at CHEST 2020 assessed the impact of macitentan on cardiac function in pulmonary arterial hypertension (PAH) and determined what role reproducible exercise echocardiographic parameters have in predicting survival.

Adding daratumumab to standard-of-care regimens consistently improves outcomes among patients with multiple myeloma, noted Mark Wildgust, PhD, vice president of Global Medical Affairs/Oncology at Janssen.

New findings in Journal of the National Cancer Institute contradict previous research indicating that assisted reproductive technology might lead to an increased risk of ovarian cancer.

Updated guidance in 6 key areas of asthma care focus on improving diagnosis, management, and treatment.

Among patients with obstructive sleep apnea (OSA), reduced dominant hand grip strength was found to correlate with lower oxygen nadir and increased apnea duration, with fat mass also consistently associated with worsening OSA indices.

The most recent data from the CDC show a 36.6% decrease in overall mortality among individuals living with HIV; despite this progress, the virus remains a leading cause of death among certain races and ethnicities.

Data from the Phase I CHRYSALIS trial also support an expanded access program that makes some patients eligible for amivantamab treatment while the FDA reviews the submission.

In a session at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts discussed challenges faced by patients with diabetes in the wake of the coronavirus disease 2019 (COVID-19) pandemic and lessons learned from the crisis.

The United States is becoming older, more diverse, and more overweight, and these changes may influence future trends in certain hematological cancers.

As higher estimated glomerular filtration rate (eGFR) equations indicate better kidney function, there has been increasing recognition that this may lead to inequitable and delayed care in treating chronic kidney disease (CKD) in Black adults.

President-elect Joe Biden will call for 100 days of mask-wearing on inauguration day; HHS announces maternal morbidity action plan; Pelosi, McConnell in virus relief talks.

Patients and health care providers evaluated the use of an electronic patient-reported outcome (ePRO) intervention for use in a clinic setting for patients with relapsed or refractory multiple myeloma (RRMM).

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
